ArticleBlood cancer journal2018

The impact of lenalidomide exposure on response and outcomes in patients with lower-risk myelodysplastic syndromes and del(5q).

Mikkael A Sekeres et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.